A patient’s groundbreaking journey through immunotherapy clinical trials


Brendan Connors was just 27 years old when he started his journey with Stage 4 Metastatic Melanoma. From Mount Sinai Hospital to National Institutes of Health (NIH) and National Cancer Institute (NCI) and finally Memorial Sloan Kettering, his immunotherapy clinical trials had him unknowingly pioneering new paths for future melanoma patients. Hear from Brendan on his years of treatments and trials, and his new vision on life. 

View More
View Less

Share this video